BRITTANY DICKERT: Open Payments
NPI 1598165474 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,456 in 126 payments from 19 companies in 2025. Trend: 2023 $3,783 · 2024 $3,788 · 2025 $2,456
Food & beverage: $2,447Education: $9
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $470 |
| PFIZER INC. | 18 | $362 |
| Janssen Biotech, Inc. | 16 | $305 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $255 |
| GENZYME CORPORATION | 9 | $181 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $172 |
| Gilead Sciences, Inc. | 5 | $124 |
| Regeneron Healthcare Solutions, Inc. | 5 | $119 |
| Madrigal Pharmaceuticals | 4 | $90 |
| QOL Medical, LLC | 5 | $70 |
Products named: TREMFYA, DUPIXENT, VELSIPITY, RINVOQ, XIFAXAN, ENTYVIO, XELJANZ, LINZESS.
Industry payments across MD — which companies pay providers there.
